|
Congestive
Citations 161-170 of 197 total displayed.
|
Past content
(since Feb 1999):
|
- Hypertension Electronic Pages
Letter: Vitamin C in Heart Failure: Hype or Hope?
- Angus K. Nightingale, Matthias Schmitt, Michael P. Frenneaux, Gianfranco Piccirillo, Marialuce Nocco, Antonio Moisè, Marco Lionetti, Camilla Naso, and Silvia Di Carlo Vincenzo Marigliano
Hypertension 2004;43: -6e; published online before print as doi:10.1161/01.HYP.0000112025.25724.8a
[Full text]
- Scientific Contributions
Nitric Oxide Mediates Benefits of Angiotensin II Type 2 Receptor Overexpression During Post-Infarct Remodeling
- Christina M. Bove, Zequan Yang, Wesley D. Gilson, Frederick H. Epstein, Brent A. French, Stuart S. Berr, Sanford P. Bishop, Hiroaki Matsubara, Robert M. Carey, and Christopher M. Kramer
Hypertension published January 19, 2004, doi:10.1161/01.HYP.0000115924.94236.91
[Abstract]
- Letters to the Editor
Vitamin C in Heart Failure: Hype or Hope?
- Angus K. Nightingale, Matthias Schmitt, and Michael P. Frenneaux
Hypertension published January 19, 2004, doi:10.1161/01.HYP.0000112025.25724.8a
[Abstract]
- Editorial Commentaries
Is Very High Sympathetic Tone in Heart Failure a Result of Keeping Bad Company?
- Murray Esler and David Kaye
Hypertension 2003;42:870-872; published online before print as doi:10.1161/01.HYP.0000098662.31444.13
[Full text]
- Scientific Contributions
Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients
- Guido Grassi, Gino Seravalle, Fosca Quarti-Trevano, Raffaella Dell’Oro, Gianbattista Bolla, and Giuseppe Mancia
Hypertension 2003;42:873-877; published online before print as doi:10.1161/01.HYP.0000098660.26184.63
[Abstract]
[Full text]
- AHA Scientific Statement
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
- Mark J. Sarnak, Andrew S. Levey, Anton C. Schoolwerth, Josef Coresh, Bruce Culleton, L. Lee Hamm, Peter A. McCullough, Bertram L. Kasiske, Ellie Kelepouris, Michael J. Klag, Patrick Parfrey, Marc Pfeffer, Leopoldo Raij, David J. Spinosa, and Peter W. Wilson
Hypertension 2003;42:1050-1065, doi:10.1161/01.HYP.0000102971.85504.7c
[Full text]
- Scientific Contributions
Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients
- Guido Grassi, Gino Seravalle, Fosca Quarti-Trevano, Raffaella Dell’Oro, Gianbattista Bolla, and Giuseppe Mancia
Hypertension published October 20, 2003, doi:10.1161/01.HYP.0000098660.26184.63
[Abstract]
- Editorial Commentary
Is Very High Sympathetic Tone in Heart Failure a Result of Keeping Bad Company?
- Murray Esler and David Kaye
Hypertension published October 20, 2003, doi:10.1161/01.HYP.0000098662.31444.13
[Abstract]
- Scientific Contributions
Alterations in G Protein and MAP Kinase Signaling Pathways During Cardiac Remodeling in Hypertension and Heart Failure
- Rachid Kacimi and Anthony Martin Gerdes
Hypertension 2003;41:968-977; published online before print as doi:10.1161/01.HYP.0000062465.60601.CC
[Abstract]
[Full text]
- Scientific Contributions
Alterations in G Protein and MAP Kinase Signaling Pathways During Cardiac Remodeling in Hypertension and Heart Failure
- Rachid Kacimi and Anthony Martin Gerdes
Hypertension published March 17, 2003, doi:10.1161/01.HYP.0000062465.60601.CC
[Abstract]
|
|
